Predictors of Disease Recurrence Post Living Donor Liver Transplantation in End Stage Chronic HCV Patients

Table 5

Correlation of HCV RNA titers, schistosoma IgG, and CMV DNA with DFS. Each of the abovementioned parameters was divided into 2 groups based on the HCV titer whether above or below the calculated median, presence or absence of IgG Ab, or presence or absence of CMV DNA were statistically compared with DFS rate.

	No. of cases	12 m DFS	𝑃 value	Sig.
		(%)
All	50	20.6
HCV PCR Before Transpl.
<43000	25	82.9	0.003	HS
>43000	25	0.0
HCV PCR Post Transpl.
<62500	25	100.0	<0.001	HS
>62500	25	0.0
Bilharzial Ab
+ve	27	51.6	0.059	NS
−ve	23	0.0
CMV PCR Post-Transpl.
−ve	30	0.0	0.801	NS
+ve	20	22.5